Canton Strategic Holdings, Inc. (CNTN)
2.14
+0.06
(+2.88%)
USD |
NASDAQ |
Sep 03, 12:54
Canton Strategic Holdings Total Liabilities (Quarterly) : 109.67M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 109.67M |
| March 31, 2026 | 114.86M |
| December 31, 2025 | 121.22M |
| September 30, 2025 | 1.545M |
| June 30, 2025 | 2.163M |
| March 31, 2025 | 2.476M |
| December 31, 2024 | 2.414M |
| September 30, 2024 | 2.234M |
| June 30, 2024 | 1.564M |
| March 31, 2024 | 1.838M |
| December 31, 2023 | 1.815M |
| Date | Value |
|---|---|
| September 30, 2023 | 1.41M |
| June 30, 2023 | 1.530M |
| March 31, 2023 | 1.521M |
| December 31, 2022 | 1.145M |
| September 30, 2022 | 0.7167M |
| June 30, 2022 | 0.7455M |
| March 31, 2022 | 1.016M |
| December 31, 2021 | 5.307M |
| September 30, 2021 | 7.560M |
| June 30, 2021 | 6.579M |
| March 31, 2021 | 5.376M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 564.57M |
| Shareholders Equity (Quarterly) | 454.90M |
| Current Ratio | 15.70 |
| Net Debt Paydown Yield | 0.05% |